Cargando…

A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging

The protozoan Trypanosoma cruzi is the causative agent of Chagas disease, one of the world’s major neglected infections. Although development of improved antiparasitic drugs is considered a priority, there have been no significant treatment advances in the past 40 years. Factors that have limited pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewis, Michael D., Francisco, Amanda Fortes, Taylor, Martin C., Kelly, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2015
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361455/ https://www.ncbi.nlm.nih.gov/pubmed/25296657 http://dx.doi.org/10.1177/1087057114552623

Ejemplares similares

Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging
por: Francisco, Amanda Fortes, et al.
Publicado: (2015)

Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against Trypanosoma cruzi
por: Scarim, Cauê Benito, et al.
Publicado: (2021)

The Trypanosoma cruzi Vitamin C Dependent Peroxidase Confers Protection against Oxidative Stress but Is Not a Determinant of Virulence
por: Taylor, Martin C., et al.
Publicado: (2015)

Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy
por: Lewis, Michael D., et al.
Publicado: (2016)

Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage
por: Francisco, Amanda Fortes, et al.
Publicado: (2016)

In Vivo Analysis of Trypanosoma cruzi Persistence Foci at Single-Cell Resolution
por: Ward, Alexander I., et al.
Publicado: (2020)

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection
por: Mann, Gurdip Singh, et al.
Publicado: (2020)

Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
por: Lewis, Michael D, et al.
Publicado: (2014)

Review on Experimental Treatment Strategies Against Trypanosoma cruzi
por: Mazzeti, Ana Lia, et al.
Publicado: (2021)

Absence of Bim sensitizes mice to experimental Trypanosoma cruzi infection
por: Hernández-Torres, Marcela, et al.
Publicado: (2021)

Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection
por: Taylor, Martin C., et al.
Publicado: (2020)

In cellulo and in vivo assays for compound testing against Trypanosoma cruzi
por: Guerra-Slompo, Eloise Pavão, et al.
Publicado: (2023)

Correction: Absence of Bim sensitizes mice to experimental Trypanosoma cruzi infection
por: Hernández-Torres, Marcela, et al.
Publicado: (2021)

Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
por: Ferreira, Daiane Dias, et al.
Publicado: (2018)

Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping
por: Costa, Fernanda Cristina, et al.
Publicado: (2018)

Immunopathological Aspects of Experimental Trypanosoma cruzi Reinfections
por: Reis Machado, Juliana, et al.
Publicado: (2014)

Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi
por: Salomão, Kelly, et al.
Publicado: (2011)

Prophylactic Efficacy of TcVac2 against Trypanosoma cruzi in Mice
por: Gupta, Shivali, et al.
Publicado: (2010)

In Vitro, In Vivo, and In Silico Studies of Cumanin Diacetate as a Potential Drug against Trypanosoma cruzi Infection
por: Sánchez Alberti, Andrés, et al.
Publicado: (2021)

Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
por: Gulin, Julián Ernesto Nicolás, et al.
Publicado: (2022)

In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi
por: Chen, Yen Ting, et al.
Publicado: (2010)

Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro
por: Bulhões Portapilla, Gisele, et al.
Publicado: (2019)

Genetic Vaccination against Experimental Infection with Myotropic Parasite Strains of Trypanosoma cruzi
por: Araújo, Adriano Fernando, et al.
Publicado: (2014)

DNA Vaccine Treatment in Dogs Experimentally Infected with Trypanosoma cruzi
por: Arce-Fonseca, Minerva, et al.
Publicado: (2020)

Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi
por: Basso, Beatriz, et al.
Publicado: (2007)

Interleukin-9 in Immunopathology of Trypanosoma cruzi Experimental Infection
por: Silva, Nadjania Saraiva de Lira, et al.
Publicado: (2021)

Phenotypic Evaluation of Nucleoside Analogues against Trypanosoma cruzi Infection: In Vitro and In Vivo Approaches
por: Fiuza, Ludmila F. de A., et al.
Publicado: (2022)

Incomplete Recruitment of Protective T Cells Is Associated with Trypanosoma cruzi Persistence in the Mouse Colon
por: Ward, Alexander I., et al.
Publicado: (2022)

Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
por: Jayawardhana, Shiromani, et al.
Publicado: (2023)

An Image-Based Algorithm for Precise and Accurate High Throughput Assessment of Drug Activity against the Human Parasite Trypanosoma cruzi
por: Moon, Seunghyun, et al.
Publicado: (2014)

Highly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” Luciferase
por: McLatchie, Alex P., et al.
Publicado: (2013)

In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection
por: Henriques, Cristina, et al.
Publicado: (2014)

Structure‐Activity Relationship of Phenylpyrazolones against Trypanosoma cruzi
por: Sijm, Maarten, et al.
Publicado: (2020)

Tambjamines and Prodiginines: Biocidal Activity against Trypanosoma cruzi
por: Herráez, Rocío, et al.
Publicado: (2021)

A Review on the Immunological Response against Trypanosoma cruzi
por: Macaluso, Giusi, et al.
Publicado: (2023)

Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
por: Planer, Joseph D., et al.
Publicado: (2014)

Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections.
por: Cardoni, Rita L, et al.
Publicado: (2004)

Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection
por: Engel, Juan C., et al.
Publicado: (1998)

Experimental and Mathematical-Modeling Characterization of Trypanosoma cruzi Epimastigote Motility
por: Sosa-Hernández, Eduardo, et al.
Publicado: (2015)

Effect of B-NIPOx in Experimental Trypanosoma cruzi Infection in Mice
por: Reséndiz-Mora, Albany, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_miqfrnpgfc0llc68i6bi9932aa